{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:54:39Z","timestamp":1760622879069},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Drug Investig."],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/bf03256908","type":"journal-article","created":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T20:33:24Z","timestamp":1362256404000},"page":"387-396","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy and Safety of the Combined Oral Contraceptive Ethinylestradiol\/ Drospirenone (Yasmin\u00ae) in Healthy Chinese Women"],"prefix":"10.1007","volume":"30","author":[{"given":"Fan","family":"Guang-Sheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bian","family":"Mei-Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Li-Nan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cao","family":"Xiao-Ming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huang","family":"Zi-Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Zi-Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xiao-Ping","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Jian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wu","family":"Shu-Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiong","family":"Cheng-Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiong","family":"Zheng-Ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Tian-Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,28]]},"reference":[{"issue":"2","key":"BF03256908_CR1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0010-7824(00)00083-4","volume":"61","author":"K.S. Parsey","year":"2000","unstructured":"Parsey KS, Pong A. An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen. Contraception 2000 Feb; 61(2): 105\u201311","journal-title":"Contraception"},{"key":"BF03256908_CR2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1749-6632.1995.tb31386.x","volume":"761","author":"P. Muhn","year":"1995","unstructured":"Muhn P, Fuhrmann U, Fritzemeier KH, et al. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Ann N Y Acad Sci 1995 Jun 12; 761: 311\u201335","journal-title":"Ann N Y Acad Sci"},{"key":"BF03256908_CR3","first-page":"413","volume-title":"Gyn\u00e4kologische Endokrinologie","author":"B. Runnenbaum","year":"1994","unstructured":"Runnenbaum B, Rabe T. Gyn\u00e4kologische Endokrinologie. Berlin: Springer Verlag 1994; 413"},{"key":"BF03256908_CR4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/13697130500330341","volume":"8Suppl.3","author":"W.H. Oelkers","year":"2005","unstructured":"Oelkers WH. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy. Climacteric 2005 Oct; 8 Suppl. 3: 19\u201327","journal-title":"Climacteric"},{"issue":"4","key":"BF03256908_CR5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1055\/s-2001-18639","volume":"19","author":"A.E. Burke","year":"2001","unstructured":"Burke AE, Blumenthal PD. Successful use of oral contraceptives. Semin Reprod Med 2001 Dec; 19(4): 313\u201321","journal-title":"Semin Reprod Med"},{"issue":"6","key":"BF03256908_CR6","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.contraception.2005.10.016","volume":"74","author":"L.E. Borges","year":"2006","unstructured":"Borges LE, Andrade RP, Aldrighi JM, et al. Effect of a combination of ethinylestradiol 30 microg and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraception. Contraception 2006 Dec; 74(6): 446\u201350","journal-title":"Contraception"},{"issue":"1","key":"BF03256908_CR7","first-page":"14","volume":"47","author":"C. Brown","year":"2002","unstructured":"Brown C, Ling F, Wan J. A new monophasic oral contraceptive containing drospirenone: effect on premenstrual symptoms. J Reprod Med 2002 Jan; 47(1): 14\u201322","journal-title":"J Reprod Med"},{"issue":"3","key":"BF03256908_CR8","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/01.grf.0000135298.39050.b3","volume":"47","author":"D.L. Dell","year":"2004","unstructured":"Dell DL. Premenstrual syndrome, premenstrual dysphoric disorder, and premenstrual exacerbation of another disorder. Clin Obstet Gynecol 2004 Sep; 47(3): 568\u201375","journal-title":"Clin Obstet Gynecol"},{"issue":"4","key":"BF03256908_CR9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0039-128X(96)00007-4","volume":"61","author":"W.K. Oelkers","year":"1996","unstructured":"Oelkers WK. Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids 1996 Apr; 61(4): 166\u201371","journal-title":"Steroids"},{"issue":"2\u20133","key":"BF03256908_CR10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0306-4530(92)90058-F","volume":"17","author":"E. Eriksson","year":"1992","unstructured":"Eriksson E, Sundblad C, Lisjo P, et al. Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls. Psychoneuroendocrinology 1992 May\u2013Jul; 17(2\u20133): 195\u2013204","journal-title":"Psychoneuroendocrinology"},{"issue":"Suppl.3","key":"BF03256908_CR11","first-page":"19","volume":"7","author":"W. Oelkers","year":"2002","unstructured":"Oelkers W. Antimineralocorticoid activity of a novel oral contraceptive containing drospirenone, a unique progestogen resembling natural progesterone. Eur J Contracept Reprod Health Care 2002 Dec; 7Suppl. 3: 19\u201326; discussion 42-3","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"2","key":"BF03256908_CR12","first-page":"113","volume":"30","author":"P.M. O\u2019Brien","year":"1985","unstructured":"O\u2019Brien PM. The premenstrual syndrome: a review. J Reprod Med 1985 Feb; 30(2): 113\u201326","journal-title":"J Reprod Med"},{"issue":"Suppl.3","key":"BF03256908_CR13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/13697130500330382","volume":"8","author":"R. Sitruk-Ware","year":"2005","unstructured":"Sitruk-Ware R. Pharmacology of different progestogens: the special case of drospirenone. Climacteric 2005 Oct; 8Suppl. 3: 4\u201312","journal-title":"Climacteric"},{"issue":"Suppl.2","key":"BF03256908_CR14","first-page":"17","volume":"6","author":"A. Teichmann","year":"2003","unstructured":"Teichmann A. Pharmacology of estradiol valerate\/ dienogest. Climacteric 2003 Aug; 6Suppl. 2: 17\u201323","journal-title":"Climacteric"},{"issue":"10\u201313","key":"BF03256908_CR15","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.steroids.2003.08.008","volume":"68","author":"W. Elger","year":"2003","unstructured":"Elger W, Beier S, Pollow K, et al. Conception and pharmacodynamic profile of drospirenone. Steroids 2003 Nov; 68(10\u201313): 891\u2013905","journal-title":"Steroids"},{"issue":"1\u20132","key":"BF03256908_CR16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.mce.2003.10.030","volume":"217","author":"W. Oelkers","year":"2004","unstructured":"Oelkers W. Drospirenone, a progestogen with antimineralocorticoid properties: a short review. Mol Cell Endocrinol 2004 Mar 31; 217(1\u20132): 255\u201361","journal-title":"Mol Cell Endocrinol"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03256908.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03256908\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03256908","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T01:24:13Z","timestamp":1558488253000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03256908"}},"subtitle":["A Randomized, Open-Label, Controlled, Multicentre Trial"],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["BF03256908"],"URL":"https:\/\/doi.org\/10.1007\/bf03256908","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}